3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Leukemia, Myeloid, Acute
11
Myelodysplastic Syndromes
9
Lymphoma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Leukemia
6
Hematologic Neoplasms
6
Neuroblastoma
4
Neoplasms
4
Melanoma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Biphenotypic, Acute
4
Leukemia, B-Cell
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Lymphoid
3
Hodgkin Disease
3
Hematologic Diseases
3
Sarcoma
2
Rhabdoid Tumor
2
Recurrence
2
Preleukemia
2
Precancerous Conditions
2
Osteosarcoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms by Histologic Type
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myeloid
2
Interventions
Bevacizumab
69
atezolizumab
54
durvalumab
43
lenvatinib
42
Nivolumab
38
pembrolizumab
35
tremelimumab
29
Magnetic Resonance Spectroscopy
21
Specimen Handling
19
tislelizumab
18
sintilimab
17
Ipilimumab
15
Sorafenib
14
regorafenib
13
cabozantinib
13
Radiosurgery
13
Radiotherapy
12
apatinib
11
Blood Specimen Collection
11
Immunoglobulin G
10
camrelizumab
9
Immune Checkpoint Inhibitors
9
Disulfides
9
X-Rays
8
Cyclophosphamide
8
donafenib
7
Oxaliplatin
7
Immunotherapy
7
Folfox protocol
7
Fluorouracil
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Mesna
×
1 year
×
Clear all
No trials found.